NLRP3 and nephrocalcinosis: However, the use of IL-1β inhibitors could not achieve the protective effect, revealing that NLRP3 inflammasome might act on nephrocalcinosis through other non-canonical pathway, possibly involving macrophage polarization and fibrosis (Anders et al., 2018).